A Randomized, Blinded, Placebo-Controlled Ascending Dose Study of the Safety and Pharmacokinetics of Dexpramipexole in Healthy Volunteers.
Phase of Trial: Phase I
Latest Information Update: 17 Dec 2014
At a glance
- Drugs Dexpramipexole (Primary)
- Indications Amyotrophic lateral sclerosis
- Focus Adverse reactions
- Sponsors Knopp Biosciences
- 27 Jan 2012 Status changed from not yet recruiting to completed as reported by ClinicalTrials.gov.
- 13 Oct 2011 New trial record